CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of respiratory diseases.
3.4.1.2. Increase in number of geriatric population.
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding use of nebulizer at homecare setting
3.4.3. Opportunities
3.4.3.1. Rise in adoption of key strategies by market players
CHAPTER 4: NEBULIZER MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Jet nebulizer
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Ultrasonic nebulizer
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Mesh nebulizer
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: NEBULIZER MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Equipment
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Accessories
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: NEBULIZER MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. COPD
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Asthma
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NEBULIZER MARKET, BY PORTABILITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Tabletop
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Portable
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
CHAPTER 8: NEBULIZER MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Hospital
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market share analysis by country
8.3. Clinics
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market share analysis by country
8.4. Homecare setting
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by region
8.4.3. Market share analysis by country
CHAPTER 9: NEBULIZER MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast By Region
9.2. North America
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast, by Type
9.2.3. Market size and forecast, by Product
9.2.4. Market size and forecast, by Application
9.2.5. Market size and forecast, by Portability
9.2.6. Market size and forecast, by End User
9.2.7. Market size and forecast, by country
9.2.7.1. U.S.
9.2.7.1.1. Market size and forecast, by Type
9.2.7.1.2. Market size and forecast, by Product
9.2.7.1.3. Market size and forecast, by Application
9.2.7.1.4. Market size and forecast, by Portability
9.2.7.1.5. Market size and forecast, by End User
9.2.7.2. Canada
9.2.7.2.1. Market size and forecast, by Type
9.2.7.2.2. Market size and forecast, by Product
9.2.7.2.3. Market size and forecast, by Application
9.2.7.2.4. Market size and forecast, by Portability
9.2.7.2.5. Market size and forecast, by End User
9.2.7.3. Mexico
9.2.7.3.1. Market size and forecast, by Type
9.2.7.3.2. Market size and forecast, by Product
9.2.7.3.3. Market size and forecast, by Application
9.2.7.3.4. Market size and forecast, by Portability
9.2.7.3.5. Market size and forecast, by End User
9.3. Europe
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast, by Type
9.3.3. Market size and forecast, by Product
9.3.4. Market size and forecast, by Application
9.3.5. Market size and forecast, by Portability
9.3.6. Market size and forecast, by End User
9.3.7. Market size and forecast, by country
9.3.7.1. Germany
9.3.7.1.1. Market size and forecast, by Type
9.3.7.1.2. Market size and forecast, by Product
9.3.7.1.3. Market size and forecast, by Application
9.3.7.1.4. Market size and forecast, by Portability
9.3.7.1.5. Market size and forecast, by End User
9.3.7.2. France
9.3.7.2.1. Market size and forecast, by Type
9.3.7.2.2. Market size and forecast, by Product
9.3.7.2.3. Market size and forecast, by Application
9.3.7.2.4. Market size and forecast, by Portability
9.3.7.2.5. Market size and forecast, by End User
9.3.7.3. UK
9.3.7.3.1. Market size and forecast, by Type
9.3.7.3.2. Market size and forecast, by Product
9.3.7.3.3. Market size and forecast, by Application
9.3.7.3.4. Market size and forecast, by Portability
9.3.7.3.5. Market size and forecast, by End User
9.3.7.4. Italy
9.3.7.4.1. Market size and forecast, by Type
9.3.7.4.2. Market size and forecast, by Product
9.3.7.4.3. Market size and forecast, by Application
9.3.7.4.4. Market size and forecast, by Portability
9.3.7.4.5. Market size and forecast, by End User
9.3.7.5. Spain
9.3.7.5.1. Market size and forecast, by Type
9.3.7.5.2. Market size and forecast, by Product
9.3.7.5.3. Market size and forecast, by Application
9.3.7.5.4. Market size and forecast, by Portability
9.3.7.5.5. Market size and forecast, by End User
9.3.7.6. Rest of Europe
9.3.7.6.1. Market size and forecast, by Type
9.3.7.6.2. Market size and forecast, by Product
9.3.7.6.3. Market size and forecast, by Application
9.3.7.6.4. Market size and forecast, by Portability
9.3.7.6.5. Market size and forecast, by End User
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast, by Type
9.4.3. Market size and forecast, by Product
9.4.4. Market size and forecast, by Application
9.4.5. Market size and forecast, by Portability
9.4.6. Market size and forecast, by End User
9.4.7. Market size and forecast, by country
9.4.7.1. Japan
9.4.7.1.1. Market size and forecast, by Type
9.4.7.1.2. Market size and forecast, by Product
9.4.7.1.3. Market size and forecast, by Application
9.4.7.1.4. Market size and forecast, by Portability
9.4.7.1.5. Market size and forecast, by End User
9.4.7.2. China
9.4.7.2.1. Market size and forecast, by Type
9.4.7.2.2. Market size and forecast, by Product
9.4.7.2.3. Market size and forecast, by Application
9.4.7.2.4. Market size and forecast, by Portability
9.4.7.2.5. Market size and forecast, by End User
9.4.7.3. India
9.4.7.3.1. Market size and forecast, by Type
9.4.7.3.2. Market size and forecast, by Product
9.4.7.3.3. Market size and forecast, by Application
9.4.7.3.4. Market size and forecast, by Portability
9.4.7.3.5. Market size and forecast, by End User
9.4.7.4. Australia
9.4.7.4.1. Market size and forecast, by Type
9.4.7.4.2. Market size and forecast, by Product
9.4.7.4.3. Market size and forecast, by Application
9.4.7.4.4. Market size and forecast, by Portability
9.4.7.4.5. Market size and forecast, by End User
9.4.7.5. South Korea
9.4.7.5.1. Market size and forecast, by Type
9.4.7.5.2. Market size and forecast, by Product
9.4.7.5.3. Market size and forecast, by Application
9.4.7.5.4. Market size and forecast, by Portability
9.4.7.5.5. Market size and forecast, by End User
9.4.7.6. Rest of Asia-Pacific
9.4.7.6.1. Market size and forecast, by Type
9.4.7.6.2. Market size and forecast, by Product
9.4.7.6.3. Market size and forecast, by Application
9.4.7.6.4. Market size and forecast, by Portability
9.4.7.6.5. Market size and forecast, by End User
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast, by Type
9.5.3. Market size and forecast, by Product
9.5.4. Market size and forecast, by Application
9.5.5. Market size and forecast, by Portability
9.5.6. Market size and forecast, by End User
9.5.7. Market size and forecast, by country
9.5.7.1. Brazil
9.5.7.1.1. Market size and forecast, by Type
9.5.7.1.2. Market size and forecast, by Product
9.5.7.1.3. Market size and forecast, by Application
9.5.7.1.4. Market size and forecast, by Portability
9.5.7.1.5. Market size and forecast, by End User
9.5.7.2. Saudi Arabia
9.5.7.2.1. Market size and forecast, by Type
9.5.7.2.2. Market size and forecast, by Product
9.5.7.2.3. Market size and forecast, by Application
9.5.7.2.4. Market size and forecast, by Portability
9.5.7.2.5. Market size and forecast, by End User
9.5.7.3. South Africa
9.5.7.3.1. Market size and forecast, by Type
9.5.7.3.2. Market size and forecast, by Product
9.5.7.3.3. Market size and forecast, by Application
9.5.7.3.4. Market size and forecast, by Portability
9.5.7.3.5. Market size and forecast, by End User
9.5.7.4. Rest of LAMEA
9.5.7.4.1. Market size and forecast, by Type
9.5.7.4.2. Market size and forecast, by Product
9.5.7.4.3. Market size and forecast, by Application
9.5.7.4.4. Market size and forecast, by Portability
9.5.7.4.5. Market size and forecast, by End User
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022
CHAPTER 11: COMPANY PROFILES
11.1. OMRON Healthcare, Inc
11.1.1. Company overview
11.1.2. Key executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. Business performance
11.2. Koninklijke Philips N.V.
11.2.1. Company overview
11.2.2. Key executives
11.2.3. Company snapshot
11.2.4. Operating business segments
11.2.5. Product portfolio
11.2.6. Business performance
11.3. PARI Respiratory Equipment Inc.
11.3.1. Company overview
11.3.2. Key executives
11.3.3. Company snapshot
11.3.4. Operating business segments
11.3.5. Product portfolio
11.3.6. Key strategic moves and developments
11.4. DeVilbiss Healthcare LLC.
11.4.1. Company overview
11.4.2. Key executives
11.4.3. Company snapshot
11.4.4. Operating business segments
11.4.5. Product portfolio
11.5. GF Health Products, Inc.
11.5.1. Company overview
11.5.2. Key executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.6. Trudell Medical International Inc.
11.6.1. Company overview
11.6.2. Key executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.7. Allied Healthcare Products, Inc.
11.7.1. Company overview
11.7.2. Key executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. Business performance
11.8. Teleflex Incorporated
11.8.1. Company overview
11.8.2. Key executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.8.6. Business performance
11.9. Rossmax International Ltd
11.9.1. Company overview
11.9.2. Key executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.9.6. Key strategic moves and developments
11.10. Vyaire Medical, Inc.
11.10.1. Company overview
11.10.2. Key executives
11.10.3. Company snapshot
11.10.4. Operating business segments
11.10.5. Product portfolio
| ※参考情報 ネブライザーとは、液体の薬物を微細な霧状にし、吸入しやすい形にする医療機器を指します。主に、呼吸器疾患治療に用いられます。例えば、喘息や慢性閉塞性肺疾患（COPD）など、気道の炎症や狭窄を伴う病気に対して、高い効果を発揮します。 ネブライザーの種類は大きく分けて、エアロゾルタイプ、超音波タイプ、圧縮型（ジェットタイプ）の三種類があります。エアロゾルタイプは、空気を圧縮して薬液を霧状にする機構があり、経済的で扱いやすいという特長があります。超音波タイプは、超音波振動を利用して薬液を微細化します。これにより、より細かい霧を生成可能で、より深く肺に到達することができます。ただし、特定の薬剤に対しては使用できない場合があります。圧縮型は、空気の流れによって気化した薬剤を吸入する方式で、広く用いられている一般的な形状です。 ネブライザーの用途は、主に呼吸器疾患の治療にとどまらず、手術後の気道の保護や、肺炎などの予防にも役立っています。また、特に小児や高齢者においては、吸入が容易であるため、その利用が増えてきています。最近では、巻き込み型やポータブル型のネブライザーも登場し、ユーザーの利便性が向上しています。 関連技術としては、薬剤の調製技術や新たな吸入デバイスの開発があります。薬剤には、吸入用のエアロゾル製品や粉末製剤が存在し、それぞれの特性を生かした製品が研鑽されています。また、ネブライザーで用いる薬剤は、気道に直接作用するため、一般的な経口薬と比べて少ない副作用で治療効果を得ることができるのも特徴です。 技術の進化に伴い、スマートデバイスとの接続機能を持ったネブライザーも登場しています。これにより、ユーザーは投与量や使用頻度を自動で記録し、副作用のモニタリングや治療効果の向上に貢献しています。また、AIを用いたデータ解析によって、個々人に適した治療法の提案や、病歴に基づいたパーソナライズドメディスンの実現も期待されています。 加えて、吸入療法を受ける患者への教育が重要視されています。正しい使用法や手入れ方法を理解することで、より効果的に治療を受けることができます。そのため、医療従事者による指導や情報提供も重要な要素です。 このように、ネブライザーは呼吸器疾患の治療において不可欠な存在となっており、その進化は今後も続くと考えられています。医療技術の発展に伴い、患者にとっての利便性や効果がさらに向上することが期待されています。これにより、より多くの人が快適な生活を送れるようになるでしょう。 ネブライザーは、治療だけでなく、予防の観点からも見直されつつあります。特に、慢性病を抱える患者にとって、日常的に使用することで、発作の防止や病状の改善が期待されるため、ますます重要な道具となっていくでしょう。今後の研究や技術の進展により、より多くの疾病に対しても適用されることが期待されています。 最後に、ネブライザーそのものの設計や性能向上が求められていく中、環境に配慮した製品開発やサステナビリティも重要なテーマとなるでしょう。これからのネブライザーには、機能性とともに環境への配慮が求められる時代が来るかもしれません。ユーザーにとって使いやすく、効果的な治療を支える技術の進化は、今後も注目されるべき課題です。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
